Alpha Teknova (TKNO) Short term Debt (2023 - 2024)

Alpha Teknova (TKNO) reported Short term Debt of $4.0 million for Q4 2024, up 60.01% quarter-over-quarter from $2.5 million in Q3 2024.

Alpha Teknova (TKNO) Short term Debt (2023 - 2024) Analysis & Trends

Alpha Teknova (TKNO) has 2 years of Short term Debt data on file, last reported at $4.0 million in Q4 2024.

Short term Debt for Q4 2024 came in at $4.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $4.0 million (changed N/A YoY), and the FY2024 annual result was $4.0 million, changed N/A from the prior year.
Short term Debt rose to $4.0 million in Q4 2024 per TKNO's latest filing, from $2.5 million in the prior quarter.
Over five years, Short term Debt peaked at $22.2 million in Q2 2023 and troughed at $1.0 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn
10	Alpha Teknova	249.27 Mn	231.49 Mn	3.78 Mn

Download Data